Xu Zhenyu 4

What Happened

• Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), sold 608 shares in open‑market transactions on May 19, 2026. The reported weighted average sale price was $4.60 per share, for total proceeds of approximately $2,798. This was a sale (not a purchase or exercise).

Key Details

• Transaction date: 2026-05-19.
• Shares sold: 608; weighted average price reported: $4.60; total proceeds: ~$2,798.
• Reported price range: $4.54 to $4.66 across multiple trades (footnote F2 — Reporting Person can provide a price-by-price breakdown on request).
• Purpose: Shares were sold to satisfy tax withholding obligations from restricted stock units that vested May 18, 2026 (footnote F1).
• Trades executed pursuant to a pre-established Rule 10b5‑1(c) plan and were non‑discretionary per the filing.
• Shares owned after the transaction: not disclosed in the provided filing.
• Filing date: 2026-05-20 (filed the day after the transaction; appears timely).

Context

• These sales were specifically to cover tax withholding on RSU vesting and were done under a 10b5‑1 plan, which is a routine and structured way insiders liquidate shares for tax or diversification needs. Such transactions do not, by themselves, indicate management sentiment about the company.